Organigram Global Inc. (OGI)
NASDAQ: OGIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
OGI stock chart
Technical analysisKey statistics
All statistics- Market cap
- $82.27M
- P/E (TTM)
- 1.36
- Forward P/E
- 27.76
- EPS (TTM)
- $0.43
- Dividend yield
- None
- 52-week range
- 0.583 – 2.24
- Day range
- 0.583 – 0.6486
- Volume / Avg
- 1.00M / 567.77K
- Beta
- —
- Shares outstanding
- 141.11M
- Next earnings
- Dec 15, 2026
52-week range
OGI stock today
On Nov 20, OGI ended the session at $0.583, shedding $0.0466 (7.40%), versus the S&P 500's 3.70% decline. Shares are 74.0% below their 52-week high of $2.24, set on Dec 18, 2025 and 0.0% above the 52-week low of $0.583, near the bottom of the past year's range. OGI is down 65.3% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 60.6%.
Organigram Global trades at 1.4x its trailing twelve-month earnings per share of $0.43. Its forward P/E of 27.8x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year. Organigram Global's next earnings report is expected on Dec 15, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Organigram Global
Company profileOrganigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. James H. Yamanaka
- Headquarters
- Toronto, ON
- Employees
- 1,139
- Website
- organigram.ca
Analyst forecast
ForecastConsensus (4 analysts)
strong_buy
- Strong buy 1
- Buy 3
- Hold 0
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Dec 15, 2026
- EPS estimate
- $0.02
OGI news
All OGI newsOrganigram Global peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| HURATuHURA Biosciences Inc. | 1.25 | -8.09% | $82.20M | vs OGI |
| NKTXNkarta Inc. | 1.14 | +1.34% | $81.29M | vs OGI |
| ANIXAnixa Biosciences Inc. | 2.44 | -6.15% | $84.82M | vs OGI |
| TLSATiziana Life Sciences Ltd. | 0.6206 | -8.14% | $79.45M | vs OGI |
| UPBUpstream Bio Inc. | 1.59 | -20.50% | $87.15M | vs OGI |
| EQEquillium Inc. | 1.06 | -5.36% | $87.26M | vs OGI |
| RTSNRetension Pharmaceuticals Inc. | 10.51 | -19.22% | $87.57M | vs OGI |
| CPIXCumberland Pharmaceuticals Inc. | 5.84 | -7.30% | $87.57M | vs OGI |
Indexes, lists and sector
Organigram Global stock FAQ
What is Organigram Global's stock price today?
OGI last traded at $0.583 as of Nov 20, 4:00 PM EST, down 7.40% on the day. Prices are delayed at least 15 minutes.
Does Organigram Global pay a dividend?
No. Organigram Global does not currently pay a regular cash dividend.
When is Organigram Global's next earnings date?
Organigram Global is expected to report earnings on Tuesday, December 15, 2026. Analysts expect EPS of $0.02.
What is OGI's P/E ratio?
OGI trades at a trailing P/E ratio of 1.36 and a forward P/E of 27.76.
Who is Organigram Global's CEO?
Mr. James H. Yamanaka is the chief executive officer of Organigram Global Inc., which has about 1,139 employees.
Has OGI ever split its stock?
Yes. The most recent OGI stock split was a 1-for-4 split on Jul 7, 2023.
What is the OGI 52-week high?
The 52-week high for OGI is $2.24 and the 52-week low is $0.583. The stock is currently 74.0% below its high.